Chandra M Sehgal Selected Research

N-hydroxysuccinimide S-acetylthioacetate (SATA)

5/2010	Antivascular ultrasound therapy extends survival of mice with implanted melanomas.
12/2007	The antivascular action of physiotherapy ultrasound on a murine tumor: role of a microbubble contrast agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chandra M Sehgal Research Topics

Disease

24	Neoplasms (Cancer) 01/2021 - 02/2002
6	Melanoma (Melanoma, Malignant) 06/2019 - 12/2007
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2019
3	Hypoxia (Hypoxemia) 01/2020 - 08/2009
2	Tendon Injuries 05/2022 - 01/2019
2	Fibrosis (Cirrhosis) 09/2020 - 01/2019
2	Ischemia 01/2020 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 10/2007 - 04/2003
2	Carcinoma (Carcinomatosis) 04/2003 - 02/2002
1	Necrosis 01/2021
1	Hyperthermia 01/2021
1	Hemorrhage 01/2021
1	Portal Hypertension 01/2021
1	Inflammation (Inflammations) 09/2020
1	Sclerosis 01/2020
1	Bronchiolitis Obliterans Syndrome 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Contracture 01/2020
1	Neoplasm Metastasis (Metastasis) 06/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Fibrosarcoma 05/2005

Drug/Important Bio-Agent (IBA)

9	Contrast MediaIBA 01/2021 - 04/2006
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 12/2005
4	perflutren (octafluoropropane)FDA Link 05/2010 - 12/2007
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 09/2020 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 09/2020 - 05/2005
2	Pharmaceutical PreparationsIBA 09/2020 - 08/2009
2	N-hydroxysuccinimide S-acetylthioacetate (SATA)IBA 05/2010 - 12/2007
2	FS 069 (Optison)FDA Link 12/2007 - 03/2006
2	Prostate-Specific Antigen (Semenogelase)IBA 10/2007 - 04/2003
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2021
1	Oxygen (Dioxygen)IBA 09/2020
1	XenonIBA 01/2020
1	Noble Gases (Rare Gases)IBA 01/2020
1	Melanins (Melanin)IBA 06/2019
1	Biological ProductsIBA 01/2019
1	HydrogelsIBA 01/2019
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2019
1	PlacebosIBA 05/2010
1	Cisplatin (Platino)FDA LinkGeneric 08/2009
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2009
1	ErbB Receptors (EGF Receptor)IBA 08/2009
1	phosphono-platelet activating factorIBA 09/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008
1	Indicators and Reagents (Reagents)IBA 10/2007
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2005
1	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 05/2005
1	chemotactic factor inactivatorIBA 07/2003
1	Interleukin-12 (IL 12)IBA 02/2002
1	Antineoplastic Agents (Antineoplastics)IBA 02/2002

Therapy/Procedure

14	Therapeutics 01/2021 - 02/2002
7	Ultrasonic Therapy 01/2021 - 06/2009
6	Microbubbles 10/2019 - 12/2007
4	Radiotherapy 09/2020 - 04/2003
2	Intravenous Administration 01/2021 - 02/2015
2	Drug Therapy (Chemotherapy) 04/2015 - 08/2009
2	Aftercare (After-Treatment) 02/2015 - 09/2008
2	Intravenous Injections 05/2010 - 09/2008
1	Lasers (Laser) 01/2020
1	Injections 01/2019
1	Palliative Care (Palliative Therapy) 01/2019
1	Precision Medicine 01/2019
1	Physical Therapy Modalities (Physical Therapy Technique) 02/2014
1	Photochemotherapy (Photodynamic Therapy) 05/2005